Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$993,031,171
+$912,803,394 QoQ
Shares Held
2,742,271
+1102.7% QoQ
Ownership
0.507%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#29
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $41,461,553,100 across 12 Drug Manufacturers - General names. AMGN ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,998,953 | $13,192,475,293 | |
| 2 | MRK |
Merck & Co., Inc.
|
86,249,283 | $11,083,032,864 | |
| 3 | JNJ |
Johnson & Johnson
|
22,588,696 | $5,736,851,118 | |
| 4 | AZN |
Astrazeneca PLC
|
28,537,243 | $5,411,232,013 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,699,683 | $1,604,477,945 | |
| 6 | ABBV |
AbbVie Inc.
|
5,055,589 | $1,272,188,413 | |
| 7 | AMGN |
Amgen Inc
This page
|
2,742,271 | $993,031,171 | |
| 8 | BIIB |
Biogen Inc.
|
3,117,469 | $673,560,350 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $993,031,171 | 2,742,271 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $80,227,777 | 228,017 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $88,443,414 | 270,213 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $27,362,957 | 96,963 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $40,057,418 | 143,467 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $80,117,571 | 257,158 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $76,543,448 | 293,675 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $77,122,249 | 239,354 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $73,242,026 | 234,412 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $72,869,222 | 256,293 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $23,041,598 | 80,000 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $36,512,118 | 135,854 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $23,973,718 | 107,980 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $21,557,814 | 89,174 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,431,016 | 54,946 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,549,821 | 55,678 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,666,160 | 56,170 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $18,771,518 | 77,626 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $20,644,145 | 91,764 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $542,836,119 | 2,552,721 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $618,055,423 | 2,535,612 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $877,808,395 | 3,528,027 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $829,627,461 | 3,608,331 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $967,202,064 | 3,805,485 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $906,450,310 | 3,843,171 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $821,982,770 | 4,054,569 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||